Publication of the interim decisions and invitation to comment for substances referred to the March 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS #33), Advisory Committees on Chemicals Scheduling (ACCS #30) and Joint Advisory Committee on Medicines and Chemicals Scheduling (Joint ACMS-ACCS #27), have been delayed.
The interim decisions and invitation for comment, which were expected to be published in June 2021, are now to be published mid-July 2021. The delay to the publication of the interim decisions and invitation to comment may cause consequential delays to delegates' final decisions. Further information on the timing of the final decisions will be published alongside the interim decisions.
